Terms: = Kidney tumors AND TOP2A, TOP2, TP2A
25 results:
1. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer.
Huang RH; Hong YK; Du H; Ke WQ; Lin BB; Li YL
J Transl Med; 2023 Jan; 21(1):20. PubMed ID: 36635710
[TBL] [Abstract] [Full Text] [Related]
2. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Novel Genes and Associated Drugs in Advanced Clear Cell Renal Cell Carcinoma by Bioinformatic Methods.
Lu M; Xiao L; Xu B; Gao Q
Tohoku J Exp Med; 2022 Aug; 258(2):79-90. PubMed ID: 35896362
[TBL] [Abstract] [Full Text] [Related]
4. Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis.
Wang X; Wang J; Lyu L; Gao X; Cai Y; Tang B
Sci Rep; 2022 Jul; 12(1):11161. PubMed ID: 35778520
[TBL] [Abstract] [Full Text] [Related]
5. Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma.
Xu H; Zheng X; Zhang S; Yi X; Zhang T; Wei Q; Li H; Ai J
Mol Cancer; 2021 Dec; 20(1):159. PubMed ID: 34872567
[TBL] [Abstract] [Full Text] [Related]
6. Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma.
Deng R; Li J; Zhao H; Zou Z; Man J; Cao J; Yang L
J Clin Lab Anal; 2021 Nov; 35(11):e24022. PubMed ID: 34606125
[TBL] [Abstract] [Full Text] [Related]
7. Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.
Yin X; Wang Z; Wang J; Xu Y; Kong W; Zhang J
Oncoimmunology; 2021; 10(1):1933332. PubMed ID: 34262797
[TBL] [Abstract] [Full Text] [Related]
8. Influence of gene expression on survival of clear cell renal cell carcinoma.
Berglund A; Amankwah EK; Kim YC; Spiess PE; Sexton WJ; Manley B; Park HY; Wang L; Chahoud J; Chakrabarti R; Yeo CD; Luu HN; Pietro GD; Parker A; Park JY
Cancer Med; 2020 Nov; 9(22):8662-8675. PubMed ID: 32986937
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Analysis of Differential Gene Expression to Identify Common Gene Signatures in Multiple Cancers.
Xue JM; Liu Y; Wan LH; Zhu YX
Med Sci Monit; 2020 Feb; 26():e919953. PubMed ID: 32035007
[TBL] [Abstract] [Full Text] [Related]
10. Proteomics and molecular network analyses reveal that the interaction between the TAT-DCF1 peptide and TAF6 induces an antitumor effect in glioma cells.
Wang J; Wang F; Li Q; Wang Q; Li J; Wang Y; Sun J; Lu D; Zhou H; Li S; Ma S; Xie J; Wen T
Mol Omics; 2020 Feb; 16(1):73-82. PubMed ID: 31899468
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating top2a.
Zhang C; Qu Y; Xiao H; Xiao W; Liu J; Gao Y; Li M; Liu J
Exp Cell Res; 2019 Nov; 384(1):111595. PubMed ID: 31505165
[TBL] [Abstract] [Full Text] [Related]
12. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma.
Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L
Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942
[TBL] [Abstract] [Full Text] [Related]
13. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.
Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN
World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617
[TBL] [Abstract] [Full Text] [Related]
14. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.
Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X
Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845
[TBL] [Abstract] [Full Text] [Related]
15. Identification of prognostic genes in kidney renal clear cell carcinoma by RNA‑seq data analysis.
Gu Y; Lu L; Wu L; Chen H; Zhu W; He Y
Mol Med Rep; 2017 Apr; 15(4):1661-1667. PubMed ID: 28260099
[TBL] [Abstract] [Full Text] [Related]
16. top2a, HELLS, ATAD2, and TET3 Are Novel Prognostic Markers in Renal Cell Carcinoma.
Chen D; Maruschke M; Hakenberg O; Zimmermann W; Stief CG; Buchner A
Urology; 2017 Apr; 102():265.e1-265.e7. PubMed ID: 28069330
[TBL] [Abstract] [Full Text] [Related]
17. Genetic and chromosomal alterations in Kenyan Wilms Tumor.
Lovvorn HN; Pierce J; Libes J; Li B; Wei Q; Correa H; Gouffon J; Clark PE; Axt JR; Hansen E; Newton M; O'Neill JA;
Genes Chromosomes Cancer; 2015 Nov; 54(11):702-15. PubMed ID: 26274016
[TBL] [Abstract] [Full Text] [Related]
18. NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells.
Wu SY; Pan SL; Xiao ZY; Hsu JL; Chen MC; Lee KH; Teng CM
PLoS One; 2014; 9(11):e112220. PubMed ID: 25372714
[TBL] [Abstract] [Full Text] [Related]
19. Mitoxantrone inhibits HIF-1α expression in a topoisomerase II-independent pathway.
Toh YM; Li TK
Clin Cancer Res; 2011 Aug; 17(15):5026-37. PubMed ID: 21653687
[TBL] [Abstract] [Full Text] [Related]
20. Large-scale integration of microarray data reveals genes and pathways common to multiple cancer types.
Dawany NB; Dampier WN; Tozeren A
Int J Cancer; 2011 Jun; 128(12):2881-91. PubMed ID: 21165954
[TBL] [Abstract] [Full Text] [Related]
[Next]